Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_assertion type Assertion NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_head.
- NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_assertion description "[By virtue of combining oncolysis with chk1 targeting, M2 exhibited potent antitumoral efficacy in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_provenance.
- NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_assertion evidence source_evidence_literature NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_provenance.
- NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_assertion SIO_000772 16459149 NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_provenance.
- NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_assertion wasDerivedFrom befree-2016 NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_provenance.
- NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_assertion wasGeneratedBy ECO_0000203 NP534575.RAEfPDnIGcKn8rBs7xPxs8c3AEk9vT581wcoXsBtOLTPM130_provenance.